Investing Profile

Marco Boorsma

InvestorVC
General Partner at Forbion
forbion.comAmsterdam, Netherlands
Photo of Marco Boorsma, General Partner at Forbion
cb
Forbion General Partner
$100K - $5.0M
$1.5M
18
CompanyStageDateRound SizeTotal Raised
Orbis Medicines
SeedFeb 2024$28M
$28M
Calluna Pharma
Series AJan 2024$81M
$81M
Inversago Pharma
Series COct 2022$69M
Series BSep 2020$35M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Elizabeth Douville (Amorchem), Nanna Luneborg (Forbion)
NorthSea Therapeutics
Series CDec 2021$80M
Series BJan 2020$40M
Series ADec 2017$29M
$150M
Co-investors: Oscar Slotboom (BGV (BioGeneration Ventures)), Rob de Ree (BGV (BioGeneration Ventures)), Sander Slootweg (Forbion), Dirk Kersten (Forbion)
Rectify Pharmaceuticals
Series AOct 2021$100M
$100M
Co-investors: Jason Rhodes (Atlas Venture), David Steinberg (Longwood Fund), Jodie Morrison (Atlas Venture), Rajesh Devraj (Atlas Venture)
Inflazome
Series BNov 2018$46M
$46M
Milestone Pharmaceuticals
Series DOct 2018$80M
Series CAug 2017$55M
$290M
Co-investors: Roderick Wong (RTW Investments), Debra K. Liebert (Domain Associates), Ela Borenstein (BDC Venture Capital), Eric Linsley (Mission BioCapital)
Escalier Biosciences
Series BMar 2018$19M
$19M